bispecific T-cell engager
Term · Oncology and biomedicine · MLC-T-ONC-001089
A substance made in the laboratory that can bind to two target proteins on the surface of different cells. For example, a bispecific T-cell engager may bind to a certain protein on healthy T cells (a type of immune cell) and, at the same time, to a different protein on cancer cells. This brings the T cells and cancer cells close together so the T cells can more effectively kill the cancer cells. Some bispecific T-cell engagers are being used to treat certain types of cancer, including acute lymphoblastic leukemia, multiple myeloma, lymphoma, and small cell lung cancer. They are a type of targeted therapy. Also called BiTE.
| Identifier | MLC-T-ONC-001089 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | BiTE |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-001089",
"term": "bispecific T-cell engager",
"field": "Oncology and biomedicine",
"definition": "A substance made in the laboratory that can bind to two target proteins on the surface of different cells. For example, a bispecific T-cell engager may bind to a certain protein on healthy T cells (a type of immune cell) and, at the same time, to a different protein on cancer cells. This brings the T cells and cancer cells close together so the T cells can more effectively kill the cancer cells. Some bispecific T-cell engagers are being used to treat certain types of cancer, including acute lymphoblastic leukemia, multiple myeloma, lymphoma, and small cell lung cancer. They are a type of targeted therapy. Also called BiTE.",
"synonyms": [
"BiTE"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/bispecific-t-cell-engager/"
}
Record 3,626 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.